Genome Medical Releases New Patient Insights About Cardiomyopathy Care

Patients reveal persistent gaps in genetic testing, diagnosis, and clinical trial access—and implications for advancing ...
Nasdaq

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GeneDx Recognizes Cerebral Palsy Awareness Month with Commitment to Improve Access to Testing GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes ...
Business Wire

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and ...
Seeking Alpha

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Jaguar Gene Therapy joins as founding partner to initiate a genetic testing program for SHANK3-related autism spectrum disorder and Phelan-McDermid syndrome GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx ...
Seeking Alpha

GeneDx targets $350M-$360M revenue for 2025 with 30% growth in exome and genome testing

President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted the ...
Healio

Q&A: ‘We are not as good as we think’ at identifying genetic conditions in babies

Please provide your email address to receive an email when new articles are posted on . Standard care relies on physicians suspecting genetic diseases in infants and referring them for testing. An ...
Nasdaq

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

-- A milestone in pediatric medicine, general pediatricians are now expected to play a more active role in initiating genetic testing -- -- Earlier use of exome and genome testing delivers better ...
Business Wire

Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

BOSTON--(BUSINESS WIRE)--Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing ...
WKOW

Wisconsin medical schools lead effort to expand newborn genome testing

MADISON (WKOW) -- An effort led by Wisconsin's two medical schools, University of Wisconsin School of Medicine and Public Health (Madison) and Medical College of Wisconsin (Milwaukee), is allowing for ...
Kansas City Star

KC geneticist seeks answers and more genome testing in underrepresented communities

Editor's Note: This interview is part of an ongoing Star series highlighting Kansas Citians from historically underrepresented communities and their impact on our region. The series builds on The Star ...